Free 15-minute consult No cost No obligation No Medicare card needed 4.8 4,500+ seniors treated 1 Confirm your state Start typing, or tap the arrow to see every state
Based on Phase 2 clinical trials, patients with T2DM who were inadequately managed with diet and exercise alone or were on a stable metformin regimen for at least 3 months before screening received once-weekly subcutaneous injections of tirzepatide at doses of 1 mg, 5 mg, 10 mg, or 15 mg for 26 weeks
Smaller companies with significant growth potential may be more challenging to identify, given the high failure rate for new drugs
doi: 10.1177/20420188221112490 [DOI] [PMC free article] [PubMed] [Google Scholar] 40.Cheng D, Yang S, Zhao X, Wang G
It is because your body has lost its adaptation to the GI-slowing effects, and jumping back to a full dose will likely cause the same nausea you experienced at the start
J Nutr Biochem